Skip to content

HCV viral load before therapy associated with post-treatment relapse in HIV/HCV coinfected

HIV/HCV coinfected patients who develop severe allergy to nevirapine have significantly increased risk of death

HIV/HBV coinfected patients should not take entecavir unless on anti-HIV treatment due to resistance risk

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis

IAS: Atazanavir safe and effective in HCV-coinfected patients with cirrhosis

IAS: Rectal trauma and drug use key in sexual transmission of HCV

IAS: HCV therapy does not significantly effect immune recovery of patients taking HIV therapy

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C

IAS: Hepatitis C clusters reveal international transmission among HIV-positive gay men